Cargando…

Impact of low molecular weight heparin administration on the clinical course of the COVID-19 disease

BACKGROUND: Lymphopenia is the most important criterion of mortality and discharging feature for patients infected with coronavirus disease 2019 (COVID-19). This study aimed to investigate the clinical impact of a low molecular weight heparin (LMWH) treatment on the clinical course of COVID-19. MATE...

Descripción completa

Detalles Bibliográficos
Autores principales:	YORMAZ, Burcu, ERGÜN, Dilek, TÜLEK, Baykal, ERGÜN, Recai, ARSLAN, Uğur, KANAT, Fikret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific and Technological Research Council of Turkey 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991848/ https://www.ncbi.nlm.nih.gov/pubmed/32892540 http://dx.doi.org/10.3906/sag-2006-184

Ejemplares similares

Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients
por: Tulek, Baykal, et al.
Publicado: (2013)

Flexible bronchoscopy may decrease respiratory muscle strength: premedicational midazolam in focus
por: Tulek, Baykal, et al.
Publicado: (2012)

High-Resolution Computed Tomography and Pulmonary Function Findings of Occupational Arsenic Exposure in Workers
por: Ergün, Recai, et al.
Publicado: (2017)

Impact of anemia on short-term survival in severe COPD exacerbations: a cohort study
por: Ergan, Begum, et al.
Publicado: (2016)

Role of tobacco exposure in the course of COVID‐19 disease and the impact of the disease on smoking behavior
por: Telatar, Tahsin Gökhan, et al.
Publicado: (2021)

Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014)

Rectus sheath hematoma with low molecular weight heparin administration: a case series
por: Sullivan, Laura E J, et al.
Publicado: (2014)

Heparin/low molecular weight heparins: Thrombocytopenia: 7 case reports
Publicado: (2021)

Arterial indications for the low molecular weight heparins
por: Ageno, Walter, et al.
Publicado: (2001)

Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels
por: Bengalorkar, Girish M., et al.
Publicado: (2011)

Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin
por: Chen, Jianle, et al.
Publicado: (2019)

The role of CD8(+) regulatory T cells and B cell subsets in patients with COVID-19
por: UÇARYILMAZ, Hülya, et al.
Publicado: (2022)

Meta-analysis of Different Pressing Time on the Incidence of Subcutaneous Hemorrhage of Low Molecular Weight Heparin Administration
por: Fang, Juan, et al.
Publicado: (2021)

Low-molecular-weight heparins in the treatment of venous thromboembolism
por: Ageno , Walter, et al.
Publicado: (2000)

The Effect of Low Molecular Weight Heparins on Fracture Healing
por: Kapetanakis, Stylianos, et al.
Publicado: (2015)

Low-molecular weight heparin infusion as anticoagulation for haemodialysis
por: Wong, Steve Siu-Man, et al.
Publicado: (2016)

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
por: Perna, Alessandra F., et al.
Publicado: (2020)

Management of intentional overdose of low-molecular-weight heparin
por: Lu, Clara, et al.
Publicado: (2022)

A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin
por: Tao, Ende, et al.
Publicado: (2020)

Low-Molecular-Weight Heparin and Unfractionated Heparin Decrease Th-1, 2, and 17 Expressions
por: Huang, Jing-Ning, et al.
Publicado: (2014)

Is the Incidence Trend of Heparin-Induced Thrombocytopenia Decreased by the Increased Use of Low-Molecular-Weight-Heparin?
por: Al-Eidan, Fahad A S
Publicado: (2015)

Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients
por: Volteas, Panagiotis, et al.
Publicado: (2022)

Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
por: Shute, Janis Kay
Publicado: (2023)

Why differentiate low molecular weight heparins for venous thromboembolism?
por: Fareed, Jawed, et al.
Publicado: (2007)

Update on the clinical use of the low-molecular-weight heparin, parnaparin
por: Camporese, Giuseppe, et al.
Publicado: (2009)

The potential benefits of low-molecular-weight heparins in cancer patients
por: Robert, Francisco
Publicado: (2010)

Diffuse alveolar hemorrhage associated with low molecular weight heparin
por: Hayashi, Shinichi, et al.
Publicado: (2013)

Low molecular weight heparin use in unexplained recurrent miscarriage
por: Yuksel, Halide, et al.
Publicado: (2014)

Use of low-molecular-weight heparin in COVID-19 patients
por: Kow, Chia Siang, et al.
Publicado: (2020)

Low molecular weight heparin in COVID-19: benefits and concerns
por: Makarem, Adham, et al.
Publicado: (2023)

Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar
por: Locke, Charles FS, et al.
Publicado: (2005)

The efficacy and safety of low-molecular-weight heparin and unfractionated heparin in the treatment of cerebral venous sinus thrombosis
por: Afshari, Daryoush, et al.
Publicado: (2015)

Primary myelofibrosis and pregnancy outcomes after low molecular-weight heparin administration: A case report and literature review
por: Bohîlţea, Roxana Elena, et al.
Publicado: (2017)

Mitochondrial Dysfunction, Mitophagy and Their Correlation with Perinatal Complications: Preeclampsia and Low Birth Weight
por: Yildirim, Raziye Melike, et al.
Publicado: (2022)

Measuring the anticoagulant effect of low molecular weight heparins in the critically ill
por: Crowther, Mark, et al.
Publicado: (2006)

Monitoring of treatment with low molecular weight heparins using viscoelastic devices
por: Schött, U, et al.
Publicado: (2014)

The antineoplastic effect of low-molecular-weight heparins – a literature review
por: Bochenek, Justyna, et al.
Publicado: (2013)

The Anti-Factor Xa Range For Low Molecular Weight Heparin Thromboprophylaxis
por: Wei, Matthew Y., et al.
Publicado: (2015)

Low Molecular Weight Heparin Nebulization Attenuates Acute Lung Injury
por: Xie, Nianlin, et al.
Publicado: (2017)

Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas
por: Bokas, Alexandros, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_suddrngdrb138j3d7sipjauoft